scholarly journals Dynamic change of Mycoplasma pneumoniae pneumonia in hospitalized children in a general hospital: a 3-year retrospective analysis

2020 ◽  
Vol 9 (4) ◽  
pp. 522-531
Author(s):  
Yan Xing ◽  
Dan Wang ◽  
Kai Sheng ◽  
Xiumei Xiao ◽  
Hongling Wei ◽  
...  
Keyword(s):  
Retrospective Analysis ◽  
General Hospital ◽  
Mycoplasma Pneumoniae ◽  
Dynamic Change ◽  
Hospitalized Children ◽  
Mycoplasma Pneumoniae Pneumonia

scholarly journals Correlation between chest radiographic findings and clinical features in hospitalized children with Mycoplasma pneumoniae pneumonia

PLoS ONE ◽  
2019 ◽  
Vol 14 (8) ◽  
pp. e0219463 ◽  
Author(s):  
Yeon Jin Cho ◽  
Mi Seon Han ◽  
Woo Sun Kim ◽  
Eun Hwa Choi ◽  
Young Hun Choi ◽  
...  
Keyword(s):  
Clinical Features ◽  
Mycoplasma Pneumoniae ◽  
Hospitalized Children ◽  
Radiographic Findings ◽  
Mycoplasma Pneumoniae Pneumonia

Soluble B7-H3 elevations in hospitalized children with Mycoplasma pneumoniae pneumonia

2013 ◽  
Vol 77 (4) ◽  
pp. 362-366 ◽  
Author(s):  
Zheng-Rong Chen ◽  
Guang-Bo Zhang ◽  
Yu-Qing Wang ◽  
Yong-Dong Yan ◽  
Wei-Fang Zhou ◽  
...  
Keyword(s):  
Mycoplasma Pneumoniae ◽  
Hospitalized Children ◽  
Mycoplasma Pneumoniae Pneumonia

Correlation between Vitamin A Deficiency and the Severity of Mycoplasma Pneumoniae Pneumonia in Children

2021 ◽  
Vol 7 (5) ◽  
pp. 3364-3373
Author(s):  
Teng Wang ◽  
Ping Zheng ◽  
Qian Jiang ◽  
Qianqian Sun
Keyword(s):  
Vitamin A ◽  
Mycoplasma Pneumoniae ◽  
Detection Rate ◽  
Vitamin A Deficiency ◽  
Hospitalized Children ◽  
Immunoglobulin Level ◽  
Normal Ratio ◽  
The Relationship ◽  
Immunoglobulin Levels ◽  
Mycoplasma Pneumoniae Pneumonia

Mycoplasma pneumoniae pneumonia is a problem that has attracted the attention of children’s respiratory department in recent years. The relationship between vitamin A deficiency (VA) and the severity of Mycoplasma disease (MPP) in children was studied. In this paper, the hospitalized children with Mycoplasma pneumoniae pneumonia (MPP) in our hospital were selected as the research objects, and they were divided into common type and refractory type (RMPP) for comparative experiment. The VA and immunoglobulin levels of the two groups were compared. Attention should be paid to the normal ratio of VA deficiency (CVAD) and sub deficiency (svad) in the two groups. In this paper, the relationship between infection, immunoglobulin level and VA level was analyzed. The results showed that CVAD was 27.27% in MPP group and 63.75% in RMPP group. Comparison of immunoglobulin levels between the two groups: the levels of IgM, IgA and IgG in the normal MPP group were significantly lower than those in the RMPP group. On the other hand, the detection rate of CVAD was 81.48% in RMPP with infection and 54.72% in RMPP without infection. The detection rate of CVAD in patients with infection was significantly higher than that in patients without infection. There was a correlation between VA Deficiency and MPP classification.

Clinical, radiographic and hematological characteristics of Mycoplasma pneumoniae pneumonia

2010 ◽  
Vol 0 (0) ◽  
Author(s):  
Letícia Alves Vervloet ◽  
Paulo Augusto Moreira Camargos ◽  
Damião Ranulfo Fernandes Soares ◽  
Gabriel Antônio de Oliveira ◽  
Janúncio Nunes de Oliveira
Keyword(s):  
Mycoplasma Pneumoniae ◽  
Mycoplasma Pneumoniae Pneumonia

scholarly journals Macrolide-Resistant and Macrolide-Sensitive Mycoplasma pneumoniae Pneumonia in Children Treated Using Early Corticosteroids

2021 ◽  
Vol 10 (6) ◽  
pp. 1309
Author(s):  
Hye Young Han ◽  
Ki Cheol Park ◽  
Eun-Ae Yang ◽  
Kyung-Yil Lee
Keyword(s):  
Mycoplasma Pneumoniae ◽  
Serological Test ◽  
Corticosteroid Treatment ◽  
23S Rrna ◽  
Laboratory Parameters ◽  
The Mean ◽  
Domain V ◽  
Positive Results ◽  
Mycoplasma Pneumoniae Pneumonia

We have found that early corticosteroid therapy was effective for reducing morbidity during five Korea-wide epidemics. We evaluated the clinical and laboratory parameters of 56 children who received early corticosteroid treatment for pneumonia that was caused by macrolide-resistant Mycoplasma pneumoniae (M. pneumoniae) or macrolide-sensitive M. pneumoniae between July 2019 and February 2020. All subjects had dual positive results from a PCR assay and serological test, and received corticosteroids within 24–36 h after admission. Point mutation of residues 2063, 2064, and 2067 was identified in domain V of 23S rRNA. The mean age was 6.8 years and the male:female ratio was 1.2:1 (31:25 patients). Most of the subjects had macrolide-resistant M. pneumoniae (73%), and all mutated strains had the A2063G transition. No significant differences in clinical and laboratory parameters were observed between macrolide-resistant and macrolide-sensitive M. pneumoniae groups that were treated with early dose-adjusted corticosteroids. Higher-dose steroid treatment may be needed for patients who have fever that persists for >48 h or increased biomarkers such as lactate dehydrogenase concentration at follow-up despite a usual dose of steroid therapy.

Sign in / Sign up

Export Citation Format

Share Document